The United States has reported 2,104 confirmed measles cases so far in 2026 — but weekly counts are falling. Here is what the latest CDC data means, and why right now is the critical moment to act.
Measles is one of the most contagious infections known to medicine. A single unvaccinated person exposed to the measles virus has a roughly 90% chance of becoming infected. One case can generate between 12 and 18 secondary infections in an unprotected population — a reproductive number that surpasses every other commonly circulating disease.
Yet as of June 18, 2026, the United States Centers for Disease Control and Prevention (CDC) is reporting something that public health officials cautiously call encouraging: weekly measles case counts are falling. After a surge that peaked in January and February of this year, the downward trend is now clear and consistent across multiple consecutive reporting weeks.[1]
This article explains what that trend means, what the data really tells us about risk and vulnerability, and — critically — why a period of declining cases is not the moment to relax. It is the moment to vaccinate.
The United States ended 2025 with 2,288 confirmed measles cases — the highest annual total since 1991 and a number that pushed the country's measles elimination status, achieved in 2000, into serious question.[1,2]
By mid-June 2026, the U.S. has already recorded 2,104 confirmed cases, approaching last year's record total with six months of the year remaining. The cases span 41 jurisdictions, with 2,093 cases among U.S. residents across 40 states and Washington D.C., and 11 cases among international visitors.[1]
The largest outbreak concentrations have been in South Carolina, Utah, Texas, Arizona, and Florida, though cases have reached every region of the country.
| Period | Approximate Weekly Cases | Trend |
|---|---|---|
| January 2026 (peak) | ~250–296 per week | 📈 Rapid surge |
| February 2026 | ~145–177 per week | 📈 Elevated |
| March–April 2026 | ~43–96 per week | 📉 Gradual decline |
| April 17, 2026 | 34 new cases (lowest to that date) | 📉 Significant slowdown |
| Early–mid June 2026 | Continuing downward | 📉 Downward trend confirmed |
This trajectory — while encouraging — does not mean the outbreak is over. As the CDC notes, measles cases are likely undercounted, as many mild cases go unreported or undiagnosed.[5]
The epidemiological pattern in 2026 is consistent with what we have seen in recent years: this is overwhelmingly a disease of the unvaccinated.
Measles does not affect all age groups equally. The highest hospitalization rates in 2026 have been among children under 5 years of age, a group that accounts for approximately 23% of cases but bears a disproportionate burden of severe outcomes.[3,4]
Adults over 20 also face elevated risk, particularly those born before widespread two-dose MMR vaccination programs were in place and who may have received only one dose, or none at all.
Infants under 12 months — too young to receive the MMR vaccine — are entirely dependent on community immunity for protection. When vaccination coverage in a community falls below approximately 95%, this protection disappears.
One of the most telling indicators of outbreak severity is the hospitalization rate. In 2026, approximately 6% of confirmed cases have required hospitalization — down from 11% in 2025. This represents real progress, but should not obscure the scale: with 2,104 cases, that figure translates to more than 130 people who required hospital-level care.[1,4]
| Indicator | 2025 | 2026 (to June 18) |
|---|---|---|
| Total confirmed cases | 2,288 | 2,104 |
| Hospitalization rate | 11% | 6% |
| Deaths | 3 | 0 (so far) |
| Outbreaks reported | 49 | 30 (ongoing) |
| Unvaccinated / unknown (%) | ~93% | 93% |
Measles hospitalizations most commonly involve pneumonia, severe dehydration, and respiratory failure requiring oxygen support. In some cases, measles encephalitis — brain inflammation — can occur, leading to permanent neurological damage or death. The absence of confirmed deaths in 2026 so far is a positive signal, but one that could change rapidly if vaccination coverage does not improve before autumn.
It can seem counterintuitive: if cases are going down, why act now? The answer lies in the nature of measles transmission and the seasonal dynamics of respiratory infections.
Summer and fall travel seasons significantly increase the risk of measles importations. Measles continues to circulate actively in multiple world regions, including parts of Europe, Africa, Southeast Asia, and the Western Pacific.[6] International travelers — and the communities they return to — represent a consistent source of new introductions.
If vaccination coverage remains low in those communities when an imported case arrives in August or September, the conditions for a new surge are already in place.
The return to school in August and September creates another high-risk moment. Classrooms, day care settings, and school buses are ideal environments for measles transmission. Ensuring children are fully vaccinated before school starts — rather than after an outbreak forces catch-up campaigns — is standard public health strategy for a reason.
The measles-mumps-rubella (MMR) vaccine is one of the most studied, validated, and effective tools in modern medicine. The evidence for its safety and efficacy has accumulated over more than six decades of widespread use.
Vaccination does not only protect the individual. At a community level, high MMR coverage creates a protective envelope around those who cannot be vaccinated — newborns, immunocompromised patients, and individuals with documented vaccine contraindications. This is what epidemiologists call community immunity, and it is currently under strain in the United States.
The United States declared measles eliminated in the year 2000 — defined as the absence of continuous, endemic transmission for more than 12 months. That status has been sustained for more than two decades, but the scale of the 2025 and 2026 outbreaks has drawn renewed scrutiny from public health organizations.
The Pan American Health Organization (PAHO) has been monitoring the situation, and the World Health Organization has noted that sustained outbreaks linked to vaccination coverage gaps represent a genuine threat to elimination status.[3]
Recovering and maintaining that status requires not just outbreak control, but sustained vaccination coverage above 95% in all communities. The current national average falls short of that threshold in many localities.
The 2026 measles data tells two stories simultaneously. The first is of a serious outbreak — 2,104 cases by mid-June, 130+ hospitalizations, 41 affected jurisdictions, and 93% of cases in unvaccinated or vaccine-status-unknown individuals. The second is of a turning point: a downward trend, a declining hospitalization rate, and no confirmed deaths so far this year.
The responsible reading of these two stories is not reassurance. It is opportunity.
Measles is preventable. It has been preventable for more than sixty years. The tools exist, the evidence is unambiguous, and the window created by declining case counts is real. What fills that window — whether it is vaccination programs that close the immunity gaps, or complacency that allows them to widen again — will determine what the second half of 2026 looks like for communities across the United States.
Talk to your doctor. Check your records. Vaccinate.